Charles Schwab Investment Management Inc. increased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – ...

PNC Financial Services Group Inc. boosted its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 1.2% in ...

CancerIQ, a best-in-class, cancer-focused precision health platform, today announced the launch of a new patient acquisition solution for imaging and oncology, CancerIQ Reach, at the Radiological ...

Corero Network Security (AIM: CNS) , the distributed denial of service (DDoS) protection specialists, announces the addition of Judson Thuerk to the Channel and Alliances Team as the Channel Manager ...

BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way ...

On a Zoom call last month from California, BridgeBio CEO Neil Kumar needled a colleague about the remote possibility of the ...

The price is close to the average $225,000 annual cost of Pfizer's drugs, before any discounts or rebates, although BridgeBio ...

As global markets show resilience with major U.S. indexes approaching record highs and smaller-cap indexes outperforming, investor sentiment remains cautiously optimistic amid geopolitical tensions ...

Overview: NCSOFT Corporation is a global developer and publisher of online games, with a market cap of ₩4.33 trillion. Operations: The company generates revenue primarily through the development and ...

As global markets continue to experience broad-based gains, with smaller-cap indexes notably outperforming larger counterparts, the focus on high growth tech stocks becomes increasingly relevant. In ...

During an address to the Bihari diaspora in the US, political strategist Prashant Kishor characterized Bihar as a "failed state," drawing parallels to Sudan and emphasizing the state's dire need ...

A man walks past a corporate office of Adani Group in Gurugram, India, November 22, 2024. REUTERS/Priyanshu Singh/File Photo Adani dollar bond prices fell to almost one-year lows on Monday as ...